Cleared Traditional

K243139 - Reverso Pro System

K243139 is an FDA 510(k) clearance for Reverso Pro System, manufactured by Indiba S. A. U.. The device is a Class 2 General & Plastic Surgery device with product code GEI cleared through the Traditional 510(k) pathway after a 114-day FDA review.

K243139 · Indiba S. A. U. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2025
Decision
114d
Days
Class 2
Risk

K243139 is an FDA 510(k) clearance for the Reverso Pro System. Classified as Electrosurgical, Cutting & Coagulation & Accessories within the GEI classification (a category for electrosurgical cutting and coagulation devices), Class II - Special Controls.

Submitted by Indiba S. A. U. (Sant Quirze Del Vallès (Barcelona), ES). The FDA issued a Cleared decision on January 22, 2025 after a review of 114 days - within the typical 510(k) review window.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4400 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Indiba S. A. U. devices

FDA 510(k) Submission Details - K243139

510(k) Number K243139 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 30, 2024
Decision Date January 22, 2025
Days to Decision 114 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
1d faster than avg
Panel avg: 115d · This submission: 114d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GEI Device Classification - Class 2, Special Controls

Product Code GEI Electrosurgical, Cutting & Coagulation & Accessories
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4400
Definition Validated Reprocessing Instructions And Reprocessing Validation Data For This Device Type Must Be Included In A 510(k) Submission If The Device Is Reusable And Has Specific Design Features (please Refer To Table 2 Of 82 Fr 26807, Available At Https://www.gpo.gov/fdsys/pkg/fr-2017-06-09/pdf/2017-12007.pdf).
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Consultant

A. Stein Regulatory Affairs Consulting Company , Ltd.
Amit Goren

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - GEI Electrosurgical, Cutting & Coagulation & Accessories

All 1258
Devices cleared under the same product code (GEI) and FDA review panel - the closest regulatory comparables to K243139.
CROMA Electrosurgical Generator (PRD-EMR-050)
K242983 · Creo Medical, Ltd. · Feb 2025
Venclose digiRF Generator (VCRFG1)
K250068 · Venclose, Inc. · Feb 2025
JETT Medical II
K240311 · Compex, Spol, S.R.O. · Jan 2025
Oligio X
K243929 · Wontech Co., Ltd. · Jan 2025
The ETHICON™ Total Energy System
K243067 · Ethicon Endo-Surgery, LLC (A Johnson and Johnson Company) · Jan 2025
DUET-V (Model: ESK-3261DV)
K233118 · Eunsung Global Corp · Jan 2025